换一批
换一批Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.
第一作者：
Miguel,Elas
第一单位：
National Center for Pharmacovigilance, Ministry of Health, San Salvador, El Salvador; Master's and Graduate School, Faculty of Medicine, University of El Salvador, San Salvador, El Salvador. Electronic address: melas@salud.gob.sv.
作者：
主题词
白喉-破伤风-百日咳菌苗(Diphtheria-Tetanus-Pertussis Vaccine);萨尔瓦多(El Salvador);嗜血菌菌苗(Haemophilus Vaccines);乙型肝炎疫苗(Hepatitis B Vaccines);人类(Humans);婴儿(Infant);药用制剂(Pharmaceutical Preparations);脊髓灰质炎病毒疫苗, 灭活(Poliovirus Vaccine, Inactivated);疫苗, 联合(Vaccines, Combined)
DOI
10.1016/j.vaccine.2021.07.010
PMID
34275672
发布时间
2021-08-13
- 浏览1
Vaccine
4849-4855页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
